Literature DB >> 18463144

Use of rituximab for the treatment of rheumatoid arthritis: the Latin American context.

E R Soriano1, C Galarza-Maldonado, M H Cardiel, B A Pons-Estel, L Massardo, C V Caballero-Uribe, A F Achurra-Castillo, L A Barile-Fabris, J Chávez-Corrales, J F Díaz-Coto, M H Esteva-Spinetti, M Guibert-Toledano, F Irazoque Palazuelos, M W Keiserman, A V Lomonte, L M H Mota, C Pineda Villaseñor, G S Alarcón.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18463144     DOI： 10.1093/rheumatology/ken015a

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  3 in total

1.  Challenges and opportunities for diagnosis and treatment of rheumatoid arthritis in Latin America.

Authors:  Carlos Pineda; Carlo V Caballero-Uribe
Journal:  Clin Rheumatol       Date:  2015-07-17       Impact factor: 2.980

Review 2.  Guidelines for the use of conventional and newer disease-modifying antirheumatic drugs in elderly patients with rheumatoid arthritis.

Authors:  Alejandro Díaz-Borjón
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

Review 3.  Proper management of rheumatoid arthritis in Latin America. What the guidelines say?

Authors:  Claiton V Brenol; Jorge Ivan Gamez Nava; Enrique R Soriano
Journal:  Clin Rheumatol       Date:  2015-07-23       Impact factor: 2.980
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.